What the FDA Red No. 3 Deadline Means for Sour Powder Candy Buyers

If you are planning a U.S. route for sour powder candy, the Red No. 3 deadline is a formulation and label checkpoint, not a question to delay until after sampling. KidStar SKU YMX-163 is a practical case because it is a 20 g sour powder candy program packed as 30 pcs × 20 display boxes/carton, so formula, artwork, and shelf presentation all move together quickly.

The direct answer is that U.S.-bound buyers should confirm whether the current formula uses FD&C Red No. 3, whether a compliant replacement route already exists, and whether ingredient statements and display-box artwork can stay aligned after the food deadline. That is the right first question before the quote hardens.

What the current official FDA sources say

The official dates matter more than trade rumor.

The FDA announced on January 15, 2025 that it was revoking authorization for the use of FD&C Red No. 3 in food and ingested drugs. The agency said manufacturers using FD&C Red No. 3 in food would have until January 15, 2027 to reformulate, while ingested drugs would have until January 18, 2028. The FDA also states that foods imported into the United States must comply with U.S. requirements.

The FDA later encouraged food manufacturers to accelerate the phase-out before the 2027 deadline. That did not create a new legal date, but it made the commercial expectation clearer: if a line depends on FD&C Red No. 3 today, the buyer should already ask what the post-deadline route looks like.

For a sourcing team, that means the correct question is no longer “is this issue real?” The question is “what do the official sources require, and what should we lock now before samples, artwork, and repeat planning move forward?”

Why sour powder candy feels the change early

YMX-163 is not only a formula. It is also a display-box, small-unit, color-driven product route. That matters because powder candy lines often depend on bright visual cues and quick shelf recognition.

If a U.S. route is serious, buyers should not say “we will sort color later.” They should ask:

• does the current formula use FD&C Red No. 3
• is there already a compliant replacement color route
• will reformulation change taste, appearance, or sample timing
• do artwork and ingredient statements need a U.S.-specific version

The exact YMX-163 product page should anchor the discussion, and the certifications and compliance page is where the buyer should connect formula review with label control.

For YMX-163, the strongest answer is usually to treat U.S. compliance as part of the product brief now, not as a legal cleanup later.

Separate sample appeal from repeat viability

A sour powder sample can still look commercially attractive even when the repeat route is weak. That is why YMX-163 should be judged on two layers:

• sample appeal: does the current product concept make sense commercially
• repeat viability: does the U.S. route remain workable after the food deadline

Those are different decisions. If the current color route would force later reformulation, the buyer should say that explicitly in the sourcing brief.

The samples page matters here because the sample round should answer the right question. A U.S.-bound sample should not be judged only by immediate appearance if the repeat business depends on a color-compliant route.

Put formula, ingredient deck, and artwork into one buying brief

For a U.S.-targeted YMX-163 program, the brief should show:

• exact SKU: YMX-163
• pack route: 20 g × 30 pcs × 20 display boxes
• whether the project is stock-style, semi-custom, or private label
• whether the U.S. version needs a different formula or ingredient statement
• who will review the ingredient deck before production approval
• whether the buyer expects only a pre-deadline test or a route that remains usable after January 15, 2027

This links naturally with packaging customization and MOQ and lead time. If the product route needs a formula shift, buyers should expect that the commercial timeline, artwork review, and sampling logic may also shift. What matters is not pretending the answer is fixed. What matters is naming the route now.

Use the FDA deadline as a planning trigger, not a panic trigger

The official sources do not say every candy importer must stop all work immediately. They do say the legal direction is already known. The useful commercial response is planning discipline:

• verify whether the current route uses FD&C Red No. 3
• confirm whether the supplier has a compliant replacement path
• separate U.S. and non-U.S. assumptions when needed
• align formula, label, and display-box workflow before the quote hardens

That is the practical takeaway for YMX-163. A sour powder candy line can still be workable for the U.S. market, but only if the importer treats color compliance as a first-brief issue instead of a late-stage surprise.

If you want KidStar to review whether YMX-163 should stay on a general export route or move into a U.S.-specific formula and artwork brief now, share your target channel, timing, branding stage, and compliance questions through the contact page. That is the fastest way to turn the Red No. 3 deadline into a workable sourcing path.

U.S. route checklist for YMX-163

• Ask whether the current YMX-163 formula uses FD&C Red No. 3.
• Confirm whether the supplier already has a post-January 15, 2027 food-compliant route.
• Separate U.S. and non-U.S. assumptions in the RFQ if both markets matter.
• Review the ingredient deck and artwork together before treating the quote as fixed.
• Keep the exact YMX-163 product link in the brief so the formula discussion stays tied to the real SKU.

Sources reviewed

• FDA to Revoke Authorization for the Use of Red No. 3 in Food and Ingested Drugs
• FDA Encourages Food Manufacturers to Accelerate Phasing Out the Use of FD&C Red No. 3 in Foods Before 2027 Deadline
• Regulatory Status of Color Additives: FD&C Red No. 3
• KidStar SKU YMX-163 product record
• KidStar certifications and compliance page
• KidStar packaging customization page
• KidStar MOQ and lead time page